Stockreport

How Lowering Cholesterol Helped This Biotech Stock To Pop [Investor's Business Daily]

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
PDF Related news Esperion Therapeutics ( ESPR ) popped Monday after a regimen of its drug, bempedoic acid and a medicine sold by Merck ( MRK ) proved successful in cutting [Read more]